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Summary
Glucose stimulates the exocytosis of insulin secretory granules of pancreatic b cells. Granule stores are quickly refilled by
activation of posttranscriptional mechanisms that enhance the biosynthesis of granule components. Rapid replacement of
granules is important to sustain insulin secretion, since new granules appear to be preferentially released. Posttranscrip-
tional regulation of granule biogenesis includes the glucose-induced nucleocytoplasmic translocation of polypyrimidine
tract binding protein 1 (PTB1), which binds mRNAs encoding granule proteins, and thus promotes their stabilization and
translation. Glucagon-like peptide 1 (GLP-1) potentiates glucose-stimulated insulin gene expression and secretion by in-
creasing cAMP levels in b cells. Here, we show that elevation of cAMP levels causes the protein kinase A-dependent phos-
phorylation and nucleocytoplasmic translocation of PTB1, thereby preventing the rapid degradation of insulinmRNA and en-
hancing the expression of various granule proteins. Taken together, these findings identify PTB1 as a common downstream
target of glucose and GLP-1 for the posttranscriptional upregulation of granule biogenesis.Introduction
Pancreatic b cells produce insulin, the most important hormone
for the control of glucose homeostasis in chordates (Steiner,
1977). In b cells, insulin is stored within organelles termed secre-
tory granules (SGs). The elevation of glucose levels triggers the
fusion of b cell SGs with the plasma membrane and the release
of insulin. Insulin, in turn, promotes the removal and consump-
tion of glucose by peripheral tissues, thereby reducing glycemia.
Absolute and relative deficits of insulin production and secretion
lead to the development of diabetes mellitus, one of the most
common metabolic disorders in human.
In addition to stimulating SG exocytosis, glucose induces the
concerted expression of insulin and most other components
necessary for the assembly of new SGs in b cells (Goodge
and Hutton, 2000; Guest et al., 1989). Increasing evidence sug-
gests that newly-synthesized neurosecretory granules, includ-
ing insulin SGs, preferentially undergo exocytosis versus older
granules (Gold et al., 2000; Halban, 1982; Duncan et al., 2003;
Solimena and Gerdes, 2003). Thus, rapid induction of granule
biogenesis is likely to be important to sustaining insulin secre-
tion. This induction relies on both transcriptional and posttran-
scriptional mechanisms (Giddings et al., 1983; Permutt and
Kipnis, 1972; Wicksteed et al., 2001). Posttranscriptional mech-
anisms, in particular, can entirely account for the increased insu-
lin biosynthesis in the 2 hr following glucose stimulation (Itoh and
Okamoto, 1980). The rapidly increased translation of insulin
mRNA depends on its 50 and 30 untranslated regions (UTRs)
(Wicksteed et al., 2001). More recently, we have found that glu-
cose promotes the rapid nucleocytoplasmic translocation of
polypyrimidine tract binding protein 1 (PTB1) in rat pancreatic is-
lets and insulinoma INS-1 cells (Knoch et al., 2004). CytosolicCELL METABOLISM 3, 123–134, FEBRUARY 2006 ª2006 ELSEVIER INCPTB1, in turn, binds and stabilizes mRNA encoding proteins of
SGs, thus enhancing their translation. Conversely, knockdown
of PTB1 in INS-1 cells by RNA interference led to the depletion
of SGs. Taken together, these data point to PTB1 as a key factor
which posttranscriptionally regulates the expression of insulin
SG components.
Glucagon-like peptide-1 (GLP-1) is an enteric hormone that is
secreted in response to ingestion of nutrients and strongly en-
hances the insulinotropic action of glucose through the activa-
tion of its adenylate cyclase-coupled receptor, thus stimulating
cAMP production and protein kinase A (PKA)-dependent phos-
phorylation (Drucker, 2003; Hinke et al., 2004). Pharmacological
activation of PKA in rat pheochromocytoma PC12 cells was re-
cently shown to induce the phosphorylation of PTB1 on serine
16 (Xie et al., 2003). This serine is part of the nuclear export sig-
nal embedded within the N-terminal nuclear localization signal
of the protein. Its phosphorylation both in heterokaryon assays
and in Xenopus oocytes led to the accumulation of PTB1 in
the cytosol (Xie et al., 2003). The aim of the present studies
was to test whether PKA phosphorylates PTB1 and modulates
its nucleocytoplasmic transport also in b cells, thereby account-
ing, at least in part, for the ability of cAMP-elevating agents such
as GLP-1 to promote the biogenesis of insulin SGs.
Results
To investigate whether cAMP promotes the phosphorylation
and nucleocytoplasmic translocation of PTB1, INS-1 cells
were incubated with 1 mM IBMX, which inhibits cAMP-degrad-
ing phosphodiesterases. IBMX treatment led to a clear phos-
pholabeling of PTB1 compared to untreated cells (Figure 1A,
top panel). A similar pattern was detected when the same cell. DOI 10.1016/j.cmet.2005.12.008 123
A R T I C L EFigure 1. cAMP promotes the phosphorylation and nucleocytosolic translocation of PTB1 in INS-1 cells
A) Autoradiography (top panel) for PTB1 and immunoblots for phospho-PTB1 (P16S-PTB1, middle panel) and PTB1 (bottom panel) immunoprecipitated from extracts of
INS-1 cells labeled with 32P-orthophosphoric acid. Cells were kept for 1 hr in 0 mM glucose (resting) with or without 10 mM H89 before being treated with 1 mM IBMX for 2 hr.
B) Immunoblots with affinity-purified antibody P16S-PTB1 on extracts from INS-1 cells incubated with 1 mM IBMX. Cell lysates were treated or untreated with alkaline
phosphatase (AP) as described (Ort et al., 2001).
C) Immunoblots for P16S-PTB1, PTB1 and g-tubulin on cell extracts from INS-1 kept in resting medium or stimulated with 25 mM glucose, 1 mM IBMX, or 1 mM IBMX + 10
nM H89.
D) Immunomicroscopy for PTB1 (red) in INS-1 cells treated with IBMX or IBMX + H89 as in (A). Nuclei were counterstained with DAPI (blue). Scale bar represents 50 mm.
E) Confocal microscopy on INS-1 cells transfected with the indicated PTB1-GFP constructs. Nuclei were blue stained by DAPI. Scale bar represents 31 mm.
F) Number of PTB1-GFP positive nuclei from 8 fields as in (D) for each experimental condition.
P values were calculated with the Student’s t test and are indicated as follows: *p < 0.05, **p < 0.01, and ***p < 0.001. Error bars show standard deviations from at least three
independent experiments.124 CELL METABOLISM : FEBRUARY 2006
PTB1 phosphorylation and granule biogenesisextracts were immunoblotted with the antibody P16S, which
was raised against a peptide mimicking PTB1 phosphorylated
on serine 16 (Figure 1A, middle panel). Both signals, however,
were reduced by coincubation with 10 mM H89 (Figure 1A, bot-
tom panel), which inhibits PKA. Recognition of the PTB1 doublet
in IBMX-treated cells by P16S was alkaline phosphatase-sensi-
tive, hence confirming the selective reactivity of this antibody
with phosphorylated PTB1 (Figure 1B). However, serine 16
was not phosphorylated following glucose stimulation (Fig-
ure 1C). In resting INS-1 cells PTB1 was mostly found in the nu-
cleus, while in IBMX-stimulated cells this nuclear signal was re-
duced concomitantly with an increased cytosolic labeling
(Figure 1D). The IBMX-induced redistribution of PTB1 was also
inhibited by cotreatment with H89.
The relationship between phosphorylation of PTB1 on serine
16 and its nucleocytoplasmic translocation in INS-1 cells was di-
rectly tested by transient transfection of PTB1-GFP fusion con-
structs in which serine 16 was replaced either by an alanine
(S16A PTB1-GFP) or an aspartate (S16D PTB1-GFP). PTB1-
GFP and S16A PTB1-GFP were both enriched in the nuclei of
transfected INS-1 cells, whereas S16D PTB1-GFP was exclu-
sively cytosolic (Figure 1E). IBMX treatment significantly re-
duced the number of nuclei positive for PTB1-GFP, but had vir-
tually no effect on the nuclear signal for S16A PTB1-GFP and
S16D PTB1-GFP (Figure 1F). These results demonstrate that
cAMP-dependent phosphorylation on serine 16 induces the
nucleocytoplasmic translocation of PTB1 in INS-1 cells.
In b cells, cAMP activates PKA and the guanine-nucleotide
exchange factor EPAC/cAMP-GEFII (Kashima et al., 2001).
Like in PC12 cells, the phosphorylation of PTB1 in INS-1 cells
was mostly likely mediated by PKA, because serine 16 is found
within a consensus motif for phosphorylation by PKA, and be-
cause this phosphorylation was inhibited by H89. To directly as-
sess the role of PKA in PTB1 phosphorylation, the expression of
the a-catalytic subunit of PKA (PKA-Ca) was knocked down us-
ing siRNA oligos. Reduction of PKA-Ca expression following
RNAi treatment was confirmed by real-time PCR (Figure 2A)
and immunoblot (Figure 2C), while the activity of PKA in extracts
of siRNA-treated cells was assessed by in vitro phosphorylation
of a specific substrate (Figure 2B). Real-time PCR data were
normalized by parallel amplification of b-actin mRNA, whose
levels were the least affected among those of six conventional
housekeeping genes in the different experimental conditions
we used (Supplemental Experimental Procedures and Fig-
ure S1A in the Supplemental Data available with this article on-
line). Knockdown of PKA activity by w50% was accompanied
by the reduced phosphorylation of PTB1 (focus on the P16S-
PTB1 lines in Figures 2C and 2D) and nucleocytoplasmic trans-
location of PTB1 in response to IBMX (Figure 2E). Knockdown of
the regulatory subunit II of PKA (PKA-RII) led to a similar reduc-
tion of PTB1 S16 phosphorylation (Figures S1C–S1E), despite
the PKA activity, as expected, was increased (Figure S1F).
This result can be explained by taking into account the role of
PKA-RII together with A-kinase anchoring proteins in targeting
PKA-C to its substrates in vivo (Wong and Scott, 2004).
Since PKA can activate the MAP kinases MEK/1/2-ERK1/2
(Vossler et al., 1997), cells were stimulated for various lengths
of time with IBMX with or without 10 mM PD98059 or 10 mM
U0126, two selective inhibitors of MEK1/2 (Figure 2F). While
the phosphorylation of ERK1/2 induced by IBMX preceded the
phosphorylation of PTB1, its inhibition did not affect the latter,CELL METABOLISM : FEBRUARY 2006hence pointing to PKA as the kinase directly responsible for
PTB1 phosphorylation and translocation.
Next, we monitored the effect of cAMP on the expression of
SG components. The levels of b-actin mRNA in INS-1 cells
grown in normal medium were comparable with those measured
in freshly isolated rat islets (Figure S1B), whereas those of insulin
1, ICA512, PC1/3, and PC2 were 13%, 54%, 59%, and 52%, re-
spectively (Figure 3A). However, the half-lives of insulin 1 mRNA
in INS-1 cells (t1/2: 19.3 6 4.8 hr) and islets (t1/2: 16.1 6 3.6 hr)
kept in medium with 11 mM glucose were comparable (Fig-
ure 3B). In INS-1 cells incubated in resting medium, which con-
tained neither glucose nor IBMX, the half-life of insulin 1 mRNA
was reduced to 2.16 6 0.46 hr (Figure 3C), whereas in IBMX-
treated cells, also without glucose, insulin 1 mRNA levels did
not decrease. Using real-time PCR we found that in INS-1 cells
stimulated with IBMX for 2 hr following 1 hr in resting medium the
levels of insulin, ICA512, PC1/3, and PC2 mRNAs, all of which
contain PTB1 binding sites in their 30UTR, and also in the
50UTR in the case of PC2, were 197%, 250%, 233%, and
165%, respectively, compared to those in cells kept in resting
medium for 3 hr (Figure 3D). Such increments were inhibited
by H89 and were not apparent in the case of CPE, a SG protein
whose expression is not upregulated by glucose (Guest et al.,
1989), and whose mRNA, which lacks a consensus for PTB1
binding, is not stabilized by PTB1 upon glucose stimulation
(Knoch et al., 2004). The levels of insulin 1 and ICA512 mRNAs
in IBMX-treated cells were also comparable to those measured
in cells stimulated with 25 mM glucose (Figure 3E). These results
indicate that IBMX stimulation was similarly effective as maximal
glucose stimulation in restoring the levels of insulin and ICA512
mRNAs levels following their decrease upon cell incubation in
resting medium. IBMX stimulation of INS-1 cells pretreated
with actinomycin D, which inhibits transcription, still increased
insulin 1, ICA512, PC1/3, and PC2 mRNA levels by 172%,
244%, 254%, and 157%, respectively (Figure 3F). Actinomycin
D also did not prevent the glucose-stimulated increase in the
levels of these mRNAs. Conversely, IBMX treatment could not
enhance insulin, ICA512, and PC1/3 mRNA levels following
the knockdown of PKA-Ca with siRNA oligos (Figure 3G). Taken
together, these results indicate that PKA stabilizes mRNAs en-
coding various SG proteins.
We then verified that cAMP/PKA also promote the expression
of SG proteins encoded by mRNAs including PTB1 binding
sites. As previously shown (Knoch et al., 2004), glucose rapidly
increased the expression of pro-ICA512 (Figure 4A, top panel).
IBMX also enhanced the expression of pro-ICA512 (Figure 4A,
middle panel), while no additional increment was observed
upon treatment with 1 mM IBMX and 25 mM glucose (Figure 4A,
bottom panel), conceivably because at these high concentra-
tions each agent already caused a maximal stimulation. Similar
to glucose, IBMX-induced pro-ICA512 expression was already
apparent after 30 min. stimulation, i.e before PKA-dependent
PTB1 was detectable (Figure 2F). Moreover, the levels of pro-
ICA512 were higher in 1 hr rather than in 2 hr IBMX-stimulated
cells, when PTB1 phosphorylation is maximal. These data indi-
cate that glucose- and IBMX-induced expression of SG compo-
nents relies on multiple posttranslational mechanisms, some of
which become active prior to PTB1 phosphorylation and trans-
location (see more in the discussion). The induction of pro-
ICA512 by IBMX was prevented by knockdown of PKA-Ca (Fig-
ure 4B). Other SG proteins upregulated by IBMX included PC2125
A R T I C L EFigure 2. PTB1 is phosphorylated by PKA
A) PKA-Ca mRNA levels in INS-1 cells as quantified by real-time PCR 4 days after transfection with short-interfering RNA (siRNA) oligos for PKA-Ca or control scrambled
siRNA oligos. Values were normalized for b-actin mRNA.
B) PKA activity in extracts from INS-1 cells treated as in (A).
C) Immunoblots for PKA-Ca, PTB1, P16S-PTB1, and g-tubulin in extracts from INS-1 cells treated as in (A) and incubated with or without 1 mM IBMX or 1 mM IBMX + 10 mM
H89.
D) Quantification of the immunoblots showed in (C).
E) Fluorescence microscopy of INS-1 cells transfected with PTB12GFP, treated with control or PKA-Ca siRNA oligos as in (A), and then incubated with or without 1 mM
IBMX. Scale bar represents 25 mm.
F) Immunoblots for PTB1, P16S-PTB1, ERK1/2, or phospho-ERK1/2 on INS-1 cell extracts. Cells were kept in resting medium with or without 5 mM PD98059 or 10 mM
U0128 for 1 hr before treatment with 1 mM IBMX for the indicated times.
P values were calculated with the Student’s t test and are indicated as follows: *p < 0.05, **p < 0.01, and ***p < 0.001. Error bars show standard deviations from at least three
independent experiments.126 CELL METABOLISM : FEBRUARY 2006
PTB1 phosphorylation and granule biogenesisand chromogranin A (Figures 4C and 4D), whereas various pro-
teins unrelated to SGs, including g-tubulin, calnexin, mannosi-
dase II, and PDI, were unaffected (Figure 4C). The role of
PTB1 in IBMX-induced expression of SG components was di-
rectly tested by reducing PTB1 levels by RNA interference. Anal-
yses by real-time PCR and western blotting confirmed that upon
depletion of PTB1 IBMX could not any longer elicit increments in
the levels of insulin, ICA512, PC1/3, and PC2 mRNAs (Figure 4E)
and pro-ICA512 (Figure 4F). Specific knockdown of PTB1 was
validated by confirming the reduction of PTB1 mRNA and of a re-
nilla luciferase construct including at the 30UTR rat PTB1 target
sequence (Figures S1F and S1G).
To test whether PTB1 binding sites in the 30UTR of mRNAs en-
coding SG proteins are critical for regulation of gene expression
by cAMP/PKA, we independently cloned the 30UTR of ICA512
and PC2 downstream of a firefly luciferase reporter gene
(pGL3-Basic) (Figure 5A). Stimulation with IBMX did not signifi-
cantly affect luciferase activity in INS-1 cells transfected with
pGL3-Basic, but induced an w2-fold increase in cells trans-
fected with Luc-ICA512-30UTR and Luc-PC2-30UTR compared
to resting cells (Figure 5B). This increase was not observed in
cells cotreated with H89 or transfected with a Luc-PC2-30UTR
construct (Luc-PC2-30UTR-mut) in which the single consensus
site for PTB1 binding was mutated. Further evidence for the in-
volvement of PKA-induced phosphorylation in the upregulation
of gene expression was obtained by measuring luciferase activ-
ity in cells cotransfected with Luc-ICA512-30UTR and various
PTB-V5 alleles (Figure 5C). Luciferase activity was increased ap-
proximately 2- and 4-fold in cells expressing PTB-V5 and S16D
PTB-V5, respectively, compared to nontransfected cells or cells
expressing S16A PTB-V5.
Next, we tested whether GLP-1, which physiologically en-
hances glucose-stimulation of b cells by activating PKA, could
increment the expression of SG components through PTB1 sim-
ilarly to IBMX. Treatment of INS-1 cells with GLP-1 increased the
levels of both ICA512 and PC1/3 mRNAs, albeit less than IBMX,
while no significant increments were measured in the case of in-
sulin 1 and CPE mRNAs (Figure 6A). We also analyzed whether
30UTRs of SG protein mRNAs are involved in the upregulation of
gene expression by GLP-1. Treatment with GLP-1 significantly
increased the luciferase activity in INS-1 cells transfected with
Luc-ICA512-30UTR or Luc-PC2-30UTR, although less than
IBMX, while it did not affect the luciferase activity of cell trans-
fected with pGL3-Basic or Luc-PC2-30UTR-mut (Figure 6B).
Overall, the reduced effects of GLP-1 compared to IBMX corre-
lated with the lower levels of cAMP induced by the former in INS-
1 cells and purified rat islets (Figure 6C). These data strongly
suggest that PTB1 is part of the signaling pathway through
which GLP-1 rapidly enhances the translation of mRNAs encod-
ing SG proteins. Accordingly, GLP-1 treatment led to the in-
creased phosphorylation of PTB1 in both INS-1 cells and islets
(Figure 6D). The use of whole islets rather than isolated b cells
for these analyses was justified, as immunomicroscopy on rat
pancreatic tissue sections showed a comparable expression
of PTB1 in islet b and a cells (Figure 6E).
Discussion
In this study, we have shown that the induction of PKA activity by
IBMX, which increases cAMP levels in b cells, causes the phos-
phorylation and nucleocytoplasmic transport of PTB1. CytosolicCELL METABOLISM : FEBRUARY 2006PTB1, in turn, quickly upregulates the expression of insulin and
other SG components encoded by mRNAs containing PTB1
binding sites in their 30UTR. Specifically, binding of cytosolic
PTB1 to these mRNAs, as we have previously shown to occur
following glucose stimulation of b cells, leads to their stabiliza-
tion and increased translation, hence prompting the biogenesis
of insulin SGs. These findings are of physiological relevance, as
GLP-1, which activates PKA, also promotes the phosphoryla-
tion of PTB1, and conceivably, its nucleocytoplasmic transloca-
tion. Accordingly, we show that GLP-1 rapidly enhances the
levels of ICA512 and PC1/3 mRNAs and that this increment, at
least in the case of PC2, depends on the presence of a PTB1
binding site in the 30UTR. Treatment with GLP-1, however, did
not significantly increase the levels of insulin mRNA in INS-1
cells and freshly isolated islets, conceivably because cAMP
levels, and thus PTB1 phosphorylation, were lower than follow-
ing IBMX treatment. Evidence that pro-ICA512 expression was
already increased in cells stimulated with IBMX for 30 min, while
phosphorylated PTB1 was not detected before stimulation with
IBMX for 1 hr, points to the existence of multiple posttranscrip-
tional mechanisms that are sequentially activated in order to en-
hance granule biogenesis. Once activated, these mechanisms
are likely to remain operative until stimulation gradually sub-
sides. Strict dependency of some of these processes on glu-
cose presence could explain why the levels of pro-ICA512
were lower in cells stimulated for 2 hr with IBMX, but without
glucose, compared to cells equally stimulated for 1 hr only, not-
withstanding that maximal PTB1 phosphorylation was detected
after IBMX treatment for 2 hr. In vivo secretion of GLP-1 pre-
cedes the increase of hyperglycemia. Hence, PKA-dependent
PTB1 phosphorylation and translocation should already be on-
going by the time glucose levels reach the threshold required
for b cell stimulation, and thus they should be able to operate
in concert with glucose in enhancing SG biogenesis.
INS-1 cells are a widely used model system to study b cells
function (Asfari et al., 1992). While being less responsive than
primary b cells, these cells respond to stimulation with high glu-
cose for 2 hr with a 2.5- to 3-fold enhanced insulin secretion (Ort
et al., 2001) and 2-fold increased levels of total insulin (data not
shown). As in primary b cells, such increment of insulin expres-
sion can only result from enhanced mRNA translation, since in-
sulin transcription is not yet induced within this short period of
time after exposure to high glucose. Our data also indicate
that the half-life of insulin 1 mRNA in INS-1 cells and rat islets
grown in normal medium with 11 mM glucose is comparable.
Thus, our measurements in INS-1 cells are likely to be physio-
logically significant. The half-life of insulin 1 mRNA, however,
was significantly shorter than previously reported by Welsh
et al. for the combined rat insulin 1 and 2 mRNAs (Welsh et al.,
1985). These authors found indeed that the half-life of insulin
mRNA in rat islets incubated with 3.3 mM glucose is 29.0 6
6.1 hr, and that it increases by 2.6-fold (t1/2: 76.8 6 20.9 hr) in
17 mM glucose. In the same study, it was shown that in rat insu-
linoma RIN-5F cells the half-life of insulin mRNA was 26.0 6
5.1 hr in either low and high glucose, but it still increased by
2.2-fold (t1/2: 57.6 6 8.0 hr) upon treatment with cholera toxin,
which enhances cAMP levels. The reason for the discrepancy
between our results and those by Welsh and coworkers is not
clear and may be attributed, at least in part, to methodological
differences between these studies. Our mRNA decay assays,
however, show that in INS-1 cells incubated without glucose127
A R T I C L EFigure 3. cAMP/PKA-induced stabilization of SG mRNAs
A) Levels of insulin 1, ICA512, PC1/3, and PC2 mRNAs in purified rat pancreatic islets and INS-1 cells grown in normal medium with 11 mM glucose. Quantification was
performed by real-time PCR using b-actin mRNA for normalization. For each gene, the levels detected in islets were equaled to 100%.
B) Decay of [3H]-labeled insulin 1 mRNA in INS-1 cells (broken line) and purified rat islets (continuous line) incubated for up to 40 hr in normal medium with 11 mM glucose.
C) Decay of [3H]-labeled insulin 1 mRNA in INS-1 cells in 0 mM glucose (resting buffer) with (broken line) or without 1 mM IBMX (continuous line) for up to 6 hr.
D–G) Real-time PCR for the indicated SG markers and b-actin on total RNA from INS-1 cells. In (D) cells were incubated for 1 hr in resting buffer, and then for an additional
2 hr in resting buffer without (resting) or with 1 mM IBMX or 1 mM IBMX + 10 mM H89. (E) mRNA levels in cells incubated for 2 hr in resting buffer, 11 mM glucose (normal128 CELL METABOLISM : FEBRUARY 2006
PTB1 phosphorylation and granule biogenesisthe half-life of insulin 1 mRNA was only 2.166 0.46 hr. This very
short half-life is consistent with the results independently ob-
tained by real-time PCR, which showed an increment of insulin
mRNA by 2-fold after IBMX treatment for 2 hr. Notably, IBMX
treatment completely prevented the decay of insulin mRNA
and its effect was not adversely affected by blocking transcrip-
tion with actinomycin D.
In PC12 cells, which resemble b cells in respect to many of
their neuroendocrine features, treatment with forskolin induced
the phosphorylation of PTB1, but did not significantly change its
localization (Xie et al., 2003). In the case of INS-1 cells, treatment
with forskolin was surprisingly ineffective in increasing cAMP
levels as well as PTB1 phosphorylation and nucleocytoplasmic
transport (data not shown). Conceivably, IBMX-mediated inhibi-
tion of phosphodiesterases, of which PDE3B is the most rele-
vant isoform in b cells (Ahmad et al., 2000; Harndahl et al.,
2002), is more effective than forskolin-mediated activation of
b cell adenylate cyclase, which include the isoforms type I, III,
VI and VIII (Delmeire et al., 2004). Notably, we did not detect
phosphorylation of PTB1 in INS-1 cells stimulated with glucose
(this study), although we observed a redistribution of PTB1 from
the nucleus to the cytosol (Knoch et al., 2004). Translocation of
PTB1 in the cytosol without detectable changes in its phosphor-
ylation has also been observed in HeLa cells infected with polio-
virus (Back et al., 2002; Xie et al., 2003), possibly because of its
cleavage by the virus-encoded protease3Cpro (Back et al.,
2002). Glucose stimulation of pancreatic islets is also accompa-
nied by the generation of a PTB1 C-terminal proteolytic frag-
ment (Knoch et al., 2004), which is close in size to the mainly
cytosolic 26 kDa C-terminal fragment observed in poliovirus-
infected cells (Back et al., 2002). In glucose-stimulated islets,
however, such 27 kDa PTB1 fragment was only detected in
the nuclear fraction, whereas most cytosolic PTB1 migrated
as a 59 kDa polypeptide, i.e., at the molecular weight of full-
length PTB1. These differences may account for the fact that
in b cells stimulated with glucose translocation of intact PTB1
into the cytosol correlates with increased stability and transla-
tion of SG protein mRNAs, whereas in poliovirus-infected cells
cytosolic PTB1 fragments may contribute to the molecular
switching from translation to replication of polioviral RNA
(Back et al., 2002). Taken together, these findings suggest that
other mechanisms, in addition to PKA-dependent phosphoryla-
tion, can elicit the translocation of PTB1 in the cytosol. The iden-
tification of these mechanisms will be an important task for the
future. It will also be interesting to establish in which compart-
ment PKA phosphorylates PTB1, and thus whether this modifi-
cation promotes the exit of PTB1 from the nucleus or rather fa-
vors its retention in the cytosol.
The synergy of GLP-1 and glucose on insulin expression and
secretion has been proposed to occur at different levels (Hinke
et al., 2004). For instance, both glucose and GLP-1 activate cal-
cineurin by increasing the levels of intracellular Ca2+. Calci-
neurin, on one hand, can promote insulin transcription by de-
phosphorylation, and thereby activation, of the transcription
factor NFAT (nuclear factor of activated T cells). Activation ofCELL METABOLISM : FEBRUARY 2006calcineurin by somatostatin, on the other hand, has also been
shown to inhibit insulin release from mouse b cells (Renstrom
et al., 1996), thereby counteracting the stimulatory effect of glu-
cose and GLP-1 on secretion. Glucose and GLP-1 can also be
synergic in stimulating type VIII adenylate cyclase, whose activ-
ity is increased by Ca2+/calmodulin and Gsa. The activity of
Ca2+/calmodulin-activated calcineurin and cAMP-dependent
PKA may further converge in regulating the phosphorylation of
molecules involved in SG exocytosis, as both enzymes are re-
cruited to the same site at the plasma membrane by the shared
anchoring protein AKAP79/150 (Lester et al., 2001). Here, we
have demonstrated that increased nucleocytosolic transport
and binding of PTB1 to the 30UTR of mRNAs encoding SG pro-
teins is an additional pathway by which glucose and GLP-1
prompt the rapid biosynthesis of SG components, and thereby
the assembly of new insulin SGs. Taken together with previous
data (Xie et al., 2003), our findings raise the possibility that
cAMP/PKA-dependent phosphorylation of PTB1 is a posttran-
scriptional mechanism shared by different neuroendocrine cells
to promote the biogenesis of SGs.
Experimental Procedures
Antibodies
The rabbit anti-phospho-PTB1 antibody P16S was generated as described
(Xie et al., 2003) and purified by affinity chromatography using agarose beads
coupled to the immunogenic phosphopeptide. Other primary antibodies
were from the following sources: mouse monoclonal antibodies anti-PTB1
(Zymed), anti-ICA512 (Ort et al., 2001), anti-calnexin (Transduction Laborato-
ries), anti-chromogranin A (Immunon), anti-protein disulfide isomerase (PDI,
Stressgen), anti-g-tubulin (Sigma), anti-mannosidase II (Velasco et al., 1993)
and anti-V5 (Invitrogen); rabbit polyclonal antibodies anti-ERK1/2, anti-phos-
pho-ERK1/2 and anti-catalytic subunit 1 of rat PKA (PKA-Ca) (Cell Signaling),
anti-protein convertase 2 (PC2), anti-carboxypeptidase E/H (CPE) and anti-
glucagon (Chemicon), and antiregulatory subunit II of rat PKA (PKA-RII)
(Upstate); guinea pig polyclonal antibodies anti-insulin (Abcam). Goat anti-
mouse, anti-rabbit and anti-guinea pig IgG conjugated with Alexa 488 or
Alexa 568 were purchased from Molecular Probes. Goat anti-mouse and
anti-rabbit IgG conjugated to horseradish peroxidase were purchased from
Bio-Rad.
Islet isolation and cell culture
Pancreatic islets were isolated from female Wistar rats by collagenase diges-
tion and density gradient centrifugation as described previously (Gotoh et al.,
1985). Rat insulinoma INS-1 cells were cultured as described (Asfari et al.,
1992). Cells were kept in resting medium (15 mM HEPES, [pH 7.4], 5 mM
KCl, 120 mM NaCl, 24 mM NaHCO3, 1 mM MgCl2, 2 mM CaCl2, 0 mM glu-
cose, 1 mg/ml ovalbumin) for 1 hr before being stimulated for 2 hr by the
addition of 25 mM glucose, 1 mM 3-isobutyl-1-methylxanthin (IBMX, Sigma)
or 100 nM GLP-1 (Phoenix Pharmaceuticals) to the resting medium unless
otherwise indicated. Preliminary experiments showed that the INS-1 cells
placed at resting medium with 0 mM or 2.8 mM glucose for 1 hr prior to stim-
ulation with 17 mM and 25 mM glucose performed similarly in term of their
insulin secretion stimulation index, levels of RNAs for SG proteins, as well
as induction of pro-ICA512, chromogranin A and g-tubulin protein content
(data not shown). In the case of stimulation with 25 mM glucose the concen-
tration of NaCl was reduced to 70 mM in order to maintain an equal osmolar-
ity. 10 mM H89 and 5 mM PD98059 (Calbiochem) or 10 mM U0128 (Cell Signal-
ing) or 5 mg/ml actinomycin D (Sigma) were added where indicated to the
resting and stimulating media.medium), 25 mM glucose, or in resting buffer with 1 mM IBMX. (F) mRNA levels in cells preincubated with 5 mg/ml actinomycin D in resting buffer for 1 hr prior to incubation in
the same buffer with 5 mg/ml actinomycin D, with or without 1 mM IBMX, or 25 mM glucose for 2 hr. (G) mRNA levels in cells transfected with scrambled or PKA-Ca siRNA
oligos and then treated as in (D). The amount of mRNA measured in resting cells was equaled to 100% (A and D–G).
P values were calculated with the Student’s t test and are indicated as follows: *p < 0.05, **p < 0.01, and ***p < 0.001. Error bars show standard deviations from at least three
independent experiments.129
A R T I C L EFigure 4. cAMP/PKA-induced expression of SG proteins
A) Immunoblots for pro-ICA512 on extracts from INS-1 cells in 0 mM or 25 mM glucose and 1 mM IBMX, alone or in combination for the indicated times.
B) Immunoblots for the indicated proteins on extracts from INS-1 cells treated with siRNA oligos and stimulated with 1mM IBMX for 2 hr.
C) Immunoblot for pro-ICA512 and other SG (PC2, chromogranin A) or housekeeping (calnexin, mannosidase II, PDI, and g-tubulin) proteins on extracts from INS-1 cells
untreated or treated with 1 mM IBMX for 2 hr.
D) Quantification of the immunoblots shown in (C).
E and F) Real-time PCR for the indicated SG markers and b-actin on total RNA (E) and immunoblots for the indicated genes (F) on extracts from cells transfected with
pGENEClip or pGENEClip-PTB1 and then treated without (resting) or with 1 mM IBMX or 1 mM IBMX + 10 mM H89.
P values were calculated with the Student’s t test and are indicated as follows: *p < 0.05, **p < 0.01, and ***p < 0.001. Error bars show standard deviations from at least three
independent experiments.130 CELL METABOLISM : FEBRUARY 2006
PTB1 phosphorylation and granule biogenesisFigure 5. Phospho-PTB1 mediates the cAMP-de-
pendent posttranscriptional upregulation of mRNAs
encoding components of insulin SGs
A)Cartoon of pGL3-Basic derived constructs includ-
ing the 30UTRs of rat ICA512 and PC2. Motifs for
PTB1 binding in these 30UTRs are shown. In Luc-
PC2-302UTR-mut, the consensus for PTB1 binding
was mutated.
B) Dual luciferase assays in INS-1 cells cotrans-
fected with the indicated firefly luciferase constructs
and renilla luciferase. Cells were incubated in 0 mM
glucose with or without 1 mM IBMX or 1 mM IBMX
+10 mM H89. The ratio between firefly and renilla lu-
ciferase activities in resting cells was set as 100%.
C) Firefly luciferase activity was measured 4 days af-
ter cotransfection of INS-1 cells with Luc-ICA512-
30UTR and the indicated PTB-V5 alleles. To reduce
levels of endogenous cytosolic PTB1, cells were
kept overnight in 2.8 mM glucose. The histograms
show the ratio between firefly luciferase activities
(relative light units, RLU) and the expression levels
of PTB-V5 alleles in the corresponding cells, as de-
termined by immunoblot (top panels).
P values were calculated with the Student’s t test and
are indicated as follows: *p < 0.05, **p < 0.01, and
***p < 0.001. Error bars show standard deviations
from at least three independent experiments.Cloning
The cDNA encoding rat PTB1 was amplified by RT-PCR from INS-1 cell total
RNA and cloned into pcDNA3.1 (Invitrogen) or pEGFP-N1 (Clontech) using
standard protocols. The 30UTR of ICA512 (473 bp; NCBI acc. Nº: U40652)
and PC2 (209 bp, NCBI acc. Nº: M76706) were cloned into the XbaI site
downstream of the firefly luciferase cDNA in pGL3-Basic (Promega). Re-
placements of serine 16 in PTB1 or mutation of the PTB1 binding site in
the 30UTR of PC2 were carried out with the QuickChange Site-Directed Mu-
tagenesis Kit (Stratagene).
Transfection
INS-1 cells were transiently transfected with cDNA vectors using an Amaxa
electroporator, as described (Knoch et al., 2004).
Protein analysis
INS-1 cells and purified islets incubated for various lengths of time with phar-
macological agents were extracted in lysis buffer (20 mM TRIS/HCl, [pH 8.0],
140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% protease inhibitor cocktail
(Sigma) and 1% phosphatase inhibitor cocktail (Calbiochem). Protein con-
centration in the detergent soluble material was measured by BCA assayCELL METABOLISM : FEBRUARY 2006(Pierce). Cell extracts were separated by SDS-PAGE and immunoblotted
as described (Knoch et al., 2004). Chemiluminescence was performed using
the Supersignal West Pico Substrate (Pierce) and detected with a LAS 3000
Bioimaging System (Fuji). Phospholabeling was performed by metabolic la-
beling of INS-1 cells with 250 mCi 32P-ortophosphate/35 mm well for 2 hr. Fol-
lowing incubation with IBMX with or without H89, cells were extracted and
Triton X-100 soluble material was used for immunoprecipitation with the
anti-PTB1 antibody. Immunoprecipitates were separated by SDS-PAGE
and analyzed by autoradiography with a BAS 1800 II Phosphoimager (Fuji).
Immunocytochemistry
For immunocytochemistry, INS-1 cells were grown on cover slips and fixed
after treatment with 3% paraformaldehyde and permeabilized with 0.2%
saponin. Rat pancreatic tissue was fixed by immersion in 4% paraformalde-
hyde and embedded in paraffin. Microtome sections were microwaved
2 times for 5 min and permeabilized with 0.2% saponin before being sequen-
tially incubated with anti-PTB1 antibodies for 2 hr, washed, and then incu-
bated with anti-insulin or anti-glucagon antibodies for 1 hr. After washing,
cell and tissue specimen were incubated with fluorochrome-conjugated sec-
ondary antibodies for 1 hr. INS-1 cells nuclei were counterstained with DAPI.131
A R T I C L EFigure 6. Phospho-PTB1 is involved in GLP-1 stimulation in b cells
A)Real-time PCR for the indicated genes and b-actin on total RNA from INS-1 cells in 0 mM glucose without (resting) or with 100 nM GLP-1, 100 nM GLP-1 + 10 mM H89, or
1 mM IBMX.
B) Dual luciferase assays in INS-1 cells cotransfected with the indicated firefly luciferase constructs and the control renilla luciferase construct and treated as in (A).
C) cAMP levels in extracts from INS-1 cells and isolated rat islets kept at rest or stimulated with 1 mM IBMX, 100 nM GLP-1, or 25 mM glucose for 2 hr.
D) Western blots for the indicated proteins on extracts from INS-1 cells and isolated rat islets stimulated with 100 nM GLP-1 or 1 mM IBMX.
E) Coimmunostainings of rat pancreatic sections with anti-PTB1 (green) and anti-insulin or anti-glucagon antibodies (red). Scale bar represents 30 mm.
P values were calculated with the Student’s t test and are indicated as follows: *p < 0.05, **p < 0.01, and ***p < 0.001. Error bars show standard deviations from at least three
independent experiments.Image acquisition and processing were performed as described (Knoch
et al., 2004; Lacas-Gervais et al., 2004).
RNA interference
Twenty-one-mer short-interfering double-stranded RNA (siRNA) oligonucle-
otides for rat PKA-C1 (NCBI accession number: XM341661) were synthe-
sized with the Silencer siRNA Construction Kit (Ambion) using the following
primers: sense primer 1 (nt 124-145), 50-AAGAGTTCCTAGCCAAAGCCACC
TGTCTC; antisense primer 1, 50-AATG-GCTTTGGCTAGGAACTCCCTGTC132TC; sense primer 2 (nt 1003-1024), 50-AAGGTGGAAGCTCCCTTCATACCTG
TCTC; antisense primer 2, 50-AATATGAAGGGAGCTTCCACCCCTGTCTC;
sense primer 3 (nt 1112-1133), 50-AAGGAGTTTACTGAGTTTTAGCCTGTC
TC; antisense primer 3, 50-AACTAAAACTCAGTAAACTCCCCTGTCTC. Con-
trol scrambled siRNA oligonucleotides were previously described (Knoch
et al., 2004). INS-1 cells (5x105/35 mm well) were grown for 2 days before
transfection of 0.5 mg mixed siRNA oligos for PKA-C1 or scrambled oligos/
well with Lipofectamin (Invitrogen). Four days after transfection cells were
harvested or fixed for immunostaining with 3% paraformaldehyde.CELL METABOLISM : FEBRUARY 2006
PTB1 phosphorylation and granule biogenesisKnockdown of rat PTB1 was performed by cloning the following hairpin (50-T
CTCGTCATGGAAGAGTGTAAATTTCAAGAGAATTTACACTCTTCCATGACCT)
into the GeneClip U1 Hairpin vector (Promega). This hairpin was de-
signed using the siRNA Target Designer software (www.promega.com/
siRNADesigner). To verify the specificity of this hairpin-mediated RNAi, the
PTB1 target sequence (50-GTCATGGAAGAGTGTAAAT) was cloned into
the XhoI site of the siCHECK-2 vector (Promega) at the 30-end of the renilla
luciferase cDNA. Four micrograms pGENEClip-PTB1 was cotransfected with
0.5 mg siCHECK-PTB1 in INS-1 cells by electroporation (Amaxa) as described
(Knoch et al., 2004). Three days after transfection the cells were used for
stimulation experiments.
RNA labeling
Four hundred freshly isolated pancreatic islets and 7 3 105 INS-1 cells/35
mm well were cultured for 1 or 4 days, respectively, before being labeled
with 10 mCi [3H]-uridine for 4 hr in either 0 mM or 11 mM glucose. Next, cells
were incubated for up to 6 or 40 hr in 0 mM glucose with or without 1 mM
IBMX or in normal medium with 11 mM glucose. After washing the cells
with PBS, total RNA was isolated with the RNeasy Kit (Qiagen) according
to the manufacturer’s protocol. Samples were cleared from genomic DNA
by DNase digestion. Insulin 1 mRNA was isolated using a biotinylated anti-
sense oligonucleotide for rat insulin 1 (50-TTGTGGCACTTGCGGGTCCTC
CACTTCACGACGGGACTTGGG) coupled to Dynabeads M-270 Streptavidin
(Dynal) according to manufacturer’s instructions. Counts (cpm) from total
and bead-isolated RNA were measured with a Winspectral Liquid Scintilla-
tion Counter 1414 (Wallac). Counts for insulin 1 mRNA were normalized rel-
ative to the counts for total RNA measured at each of the corresponding
time points. The half-life of insulin mRNA was calculated as described (Welsh
et al., 1985).
Real-time PCR
Four hundred islets or 63 105 INS-1 cells/35 mm well were cultured for 1 or 4
days, respectively, before the extraction of total RNA. One microgram total
RNA was reversely transcribed with SuperScript II reverse transcriptase
(Invitrogen) and oligo d(T) primer. mRNA levels were measured by quantita-
tive real-time PCR with the QuantiTect SYBR Green PCR Kit (QIAGEN) and
a MX4000 Thermocycler (Stratagene). Normalization of real-time PCR data
was performed by parallel amplification of rat b-actin mRNA (see also Sup-
plemental Experimental Procedures and Figure S1A). Primers for b-actin, in-
sulin and ICA512 have been previously described (Steinbrenner et al., 2002).
For additional genes we used the following primers: PKA-C1, sense: 50-GCT
CACTGAACCTCCCAATCC, antisense: 50-GAACCACTATGCCATGAAGATC;
PC1/3, sense: 50-GTACCCAAAAACTCCAGCAG, antisense: 50-GGCTTGTT-
GAGCTTTTCCAG; PC2, sense: 50-TAGGGCCACGCTTCCGC, antisense:
50-GGTAGGAACGCTATATTTGGG; CPE, sense: 50-TTGGGAACATGCATG
GTAATGAG, antisense: 50-CACGAACCAGTCCTTCAGCTC.
Luciferase Assays
For dual luciferase assays INS-1 cells were cotransfected with firefly lucifer-
ase constructs and phRL (Promega) encoding renilla luciferase. The firefly lu-
ciferase activity was measured 4 days after transfection and normalized ver-
sus that of renilla luciferase.
PKA Activity
Enzymatic activity of PKA in cell extracts (0.2 mg) was quantified with the non-
radioactive PKA Kinase Activity Assay Kit (Stressgen) according to manufac-
turer’s instructions. Absorbance at 450 nm was measured with a microplate
reader (Anthos). Activity was defined as the difference between measured
absorbance without and in the presence of 6 mM PKA inhibitor peptide
(Upstate).
Quantification of cAMP Levels
cAMP amounts in INS-1 cells and isolated islets after incubation in resting
buffer or with IBMX, GLP-1 or glucose were measured using the Cyclic
AMP EIA kit (Cayman Chemical) according to the manufacturer’s instruc-
tions.
Statistics
SigmaStat 3.0 (SPSS Inc.) was used for statistical analyses. p values were
calculated with the Student’s t test and indicated in the figures as follows:CELL METABOLISM : FEBRUARY 2006*p < 0.05, **p < 0.01 and ***p < 0.001. Error bars show standard deviations
from at least three independent experiments.
Supplemental data
Supplemental Data include Supplemental Experimental Procedures and one
figure and can be found with this article online at http://www.cellmetabolism.
org/cgi/content/full/3/2/123/DC1/.
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